 |
|
A large step forward in the fight against African sleeping sickness
April 10, 2006Each year, over 300,000 people die of African sleeping sickness (trypanosomiasis). Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to the Free University of Brussels are making strides in the battle against this disease. They have coupled the human protein ApoL-1 with a nanobody in order to very specifically eliminate the infection caused by the pathogenic parasites, against which our defense mechanism is powerless. Tests on mice are already promising. The recently published research results offer new possibilities for people who have contracted this disease.
African sleeping sickness
About 400,000 people worldwide suffer from the deadly African sleeping sickness. The disease produces severe sleep disorders that ultimately end in coma, followed by death. At present, fewer than 10% of the patients are treated in time. But on the other hand, the current treatment is also very toxic, and in many cases also results in the patient's death.
African sleeping sickness is a disorder caused by the trypanosome parasite. The blood-sucking tsetse fly transmits the parasite from person to person. Once someone has been infected by the parasite, the person's body has great difficulty getting the infection under control, because the parasite constantly changes appearance. Thus, the trypanosome remains impervious to the antibodies that the body produces.
Parasite eludes human defense mechanism
Fortunately, our body has a special defense mechanism that can help us in the fight against African trypanosomes. Our blood contains ApoL-1, which is toxic to - and neutralizes - most types of trypanosomes.
However, there is one trypanosome against which we are not protected: Trypanosoma brucei rhodesiense. This parasite is resistant to ApoL-1, because it has particular proteins that counteract ApoL-1's action.
For some time now, scientists have known that a variant of ApoL-1 is not neutralized by Trypanosoma brucei rhodesiense. This truncated ApoL-1 variant can help to overcome the parasite that infects our body, but only when it is present in very high concentrations. The challenge for the researchers was to get this truncated ApoL-1 variant efficiently to the place where it is needed: onto the surface of the parasite.
Nanobody carries ApoL-1 variant to the parasite
Under the direction of Serge Muyldermans and Patrick De Baetselier, VIB researchers have previously produced a nanobody (a very small antibody) that targets and binds to the parasite very specifically (Stijlemans et al., 2004). Toya Nath Baral and his VIB colleagues have now succeeded in coupling this nanobody to the abbreviated ApoL-1 variant. This creates a special product that binds immediately to the parasite and thus brings the ApoL-1 variant to the place where it can carry out its neutralizing action.
All the tests performed on mice have been very promising: Trypanosome-infected mice survive after 1 treatment. The parasite is removed from the blood and all effects associated with the disease disappear. There is every indication that this substance can also counteract Trypanosoma brucei rhodesiense in humans - sparing them from African sleeping sickness.
VIB, Flanders Interuniversity Institute of Biotechnology
African sleeping sickness is a disorder caused by the trypanosome parasite. The blood-sucking tsetse fly transmits the parasite from person to person. Once someone has been infected by the parasite, the person's body has great difficulty getting the infection under control, because the parasite constantly changes appearance. Thus, the trypanosome remains impervious to the antibodies that the body produces.
Parasite eludes human defense mechanism
Fortunately, our body has a special defense mechanism that can help us in the fight against African trypanosomes. Our blood contains ApoL-1, which is toxic to - and neutralizes - most types of trypanosomes.
However, there is one trypanosome against which we are not protected: Trypanosoma brucei rhodesiense. This parasite is resistant to ApoL-1, because it has particular proteins that counteract ApoL-1's action.
For some time now, scientists have known that a variant of ApoL-1 is not neutralized by Trypanosoma brucei rhodesiense. This truncated ApoL-1 variant can help to overcome the parasite that infects our body, but only when it is present in very high concentrations. The challenge for the researchers was to get this truncated ApoL-1 variant efficiently to the place where it is needed: onto the surface of the parasite.
Nanobody carries ApoL-1 variant to the parasite
Under the direction of Serge Muyldermans and Patrick De Baetselier, VIB researchers have previously produced a nanobody (a very small antibody) that targets and binds to the parasite very specifically (Stijlemans et al., 2004). Toya Nath Baral and his VIB colleagues have now succeeded in coupling this nanobody to the abbreviated ApoL-1 variant. This creates a special product that binds immediately to the parasite and thus brings the ApoL-1 variant to the place where it can carry out its neutralizing action.
All the tests performed on mice have been very promising: Trypanosome-infected mice survive after 1 treatment. The parasite is removed from the blood and all effects associated with the disease disappear. There is every indication that this substance can also counteract Trypanosoma brucei rhodesiense in humans - sparing them from African sleeping sickness.
VIB, Flanders Interuniversity Institute of Biotechnology
African Sleeping Sickness Current Events and African Sleeping Sickness News RSSScans show immune cells intercepting parasites
Researchers may have identified one of the body's earliest responses to a group of parasites that causes illness in developing nations.
New UNC laboratory to help track and control tropical diseases
The University of North Carolina at Chapel Hill School of Public Health has established a new Gillings Innovation Lab to track and map tropical infectious diseases such as malaria, using state-of-the-art molecular and demographic methods.
New drug combination shows promise for African sleeping sickness
A small clinical trial in Uganda, conducted within a long-established Médecins Sans Frontières (MSF) treatment program for African sleeping sickness, has found that a new combination treatment using the drugs nifurtimox and eflornithine holds promise and deserves further evaluation.
Study finds multiple neglected tropical diseases effectively treated with drugs
The neglected tropical diseases are a group of 13 infectious diseases, including elephantiasis, hookworm, African sleeping sickness and trachoma, which affect more than 1 billion people worldwide, most of whom live in extreme poverty.
UGA researchers discover how human body fights off African parasite
Trypanosoma are a nasty class of single-celled parasites that cause serious, even fatal, diseases in human and animals.
Scientists identify a gene that may suppress colorectal cancer
In today's online edition of Genome Research, a husband-and-wife research team from Thomas Jefferson University report the discovery of a gene that, when mutated, may suppress colorectal cancer.
African parasite makes component of fat differently from all other organisms
Studying the parasite that causes African sleeping sickness, scientists at Johns Hopkins have discovered a previously unknown way of making fatty acids, a component of fat and the outer layer of all cells.
Toward the future of cancer prevention
Can most types of cancers be prevented? It's a question that has emerged in the past 20 years, given advances in screening and early diagnosis, rapid developments in genetics and molecular biology, and progress in the treatment of early disease and in next-generation targeted therapies.
MBL study shows how good cholesterol (HDLs) provide human immunity to certain parasites
For years biomedical researchers have known that high density lipoproteins, commonly called HDLs or "good cholesterol," are responsible for protecting humans from certain parasites, but couldn't explain how.
Compound might defeat African sleeping sickness, clinical trial beginning this month
One of the most devastating diseases in sub-Saharan Africa almost disappeared in the late 1950s. That disease, African sleeping sickness, or trypanosomiasis, largely succumbed to heroic public health efforts - including relocating entire villages.
More African Sleeping Sickness Current Events and African Sleeping Sickness News Articles
 |
African Sleeping Sickness - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications (Author) In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most advanced tools available and spending the least amount of time doing so. |
![African Sleeping Sickness Mini Plush in Petri Dish by Giant Microbes [Toy] [Toy]](http://ecx.images-amazon.com/images/I/31Po4BTU7bL._SL160_.jpg) |
African Sleeping Sickness Mini Plush in Petri Dish by Giant Microbes [Toy] [Toy] by Giant Microbes set of 3 mini plush African Sleeping Sickness microbes in their very own petri dish by Giant Microbes |
|
African Sleeping sickness: Stories & Poems by Wanda Coleman (Author) | |
|
African Sleeping Sickness: Political Ecology, Colonialism, and Control in Uganda (Studies in African Health and Medicine) by Jonathan Musere (Author) Based on an interplay of bio-ecology, medicine, anthropology, history, and sociopolitics, this work compares and contrasts the role of communalist traditional, colonial, and postcolonial agencies in the control or eruption of trypanosomiasis (sleeping sickness) in man and cattle in Uganda. | |
|
African Sleeping Sickness: Stories and Poems by Wanda Coleman (Author) | |
 |
African Sleeping Sickness: Stories and Poems by Wanda Coleman (Author) Coleman is one of the decade's most moral poets, showing us in feverishly focused first- and third-person dramatic monologues the grim life of L.A.'s streets. It's impossible to paraphrase her colloquial, dynamic style: "where I live / the little gangsters diddy-bop through and pick up / young bitches and flirt with old ones, looking to / snatch somebody's purse or find their way into somebody's / snatch 'cause mama don't want them at home and papa / is a figment and them farms them farms them farms / they call schools, and mudflapped bushy-headed entities / swoop the avenue seeking death / it's the only thrill left / where I live." Understanding does not mean, to Coleman, mild forgiveness, it means hot rage against those of any color who prey on others in pain. Contextualizing murder,... |
|
Progress in Human African Trypanosomiasis, Sleeping Sickness by Michel Dumas (Author), Bernard Bouteille (Author), Alain Buguet (Author) Human African Trypaniosomiasis (HAT) or sleeping sickness is an old disease to be now considered as reemergent. HAT is endemic in 36 sub-Saharan African countries, in areas where tsetse flies are found. The public health importance of HAT is underestimated, but the disease causes severe social disruption in many rural areas. Along the past fifteen years, numerous studies were made, and now, the mechanisms involved in the disease pathogenesis and in the characteristics of sleep-wake disruption become to be better understood. But, since 50 years, when current drugs were introduced, problems regarding HAT chemotherapy have not been solved. Nevertheless, in-depth studies about trypanosome metabolism have permitted to discover new drug targets. Written by specialists who are very experienced... | |
|
Sleeping Sickness and Other Parasitic Tropical Diseases (Epidemics) by Fred Ramen (Author) Examines the microscopic world of the parasites that cause sleeping sickness and explains the origin of tropical diseases and their history. | |
 |
Lords of the Fly: Sleeping Sickness Control in British East Africa, 1900-1960 by Kirk A. Hoppe (Author) British sleeping sickness control in colonial Uganda and Tanzania became a powerful mechanism for environmental and social engineering that defined and delineated African landscapes, reordered African mobility and access to resources. As colonialism shifted from conquest to occupation, colonial scientists exercised much influence during periods of administrative uncertainty about the role and future of colonial rule. "Impartial" and "objective" science helped to justify the British "civilizing mission" in East Africa by muting the moral ambiguities and violence of colonial occupation. |
|
African sleeping sickness.(SLEEP MEDICINE): An article from: FOCUS: Journal for Respiratory Care & Sleep Medicine by Frank Roman (Author) This digital document is an article from FOCUS: Journal for Respiratory Care & Sleep Medicine, published by Focus Publications, Inc. on September 1, 2008. The length of the article is 1242 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: African sleeping sickness.(SLEEP MEDICINE) Author: Frank Roman Publication: FOCUS: Journal for Respiratory Care & Sleep Medicine (Magazine/Journal) Date: September 1, 2008 Publisher: Focus Publications, Inc. Page: 48(2) Distributed by Gale, a part of Cengage... |
| © 2009 BrightSurf.com |